Ocular Therapeutix (OCUL) Receivables (2016 - 2025)
Historic Receivables for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $30.6 million.
- Ocular Therapeutix's Receivables fell 536.62% to $30.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.6 million, marking a year-over-year decrease of 536.62%. This contributed to the annual value of $30.6 million for FY2025, which is 536.62% down from last year.
- Latest data reveals that Ocular Therapeutix reported Receivables of $30.6 million as of Q4 2025, which was down 536.62% from $30.8 million recorded in Q3 2025.
- Ocular Therapeutix's 5-year Receivables high stood at $32.4 million for Q4 2024, and its period low was $13.6 million during Q1 2021.
- Its 5-year average for Receivables is $24.6 million, with a median of $24.4 million in 2023.
- In the last 5 years, Ocular Therapeutix's Receivables soared by 55184.41% in 2021 and then tumbled by 897.57% in 2023.
- Ocular Therapeutix's Receivables (Quarter) stood at $21.1 million in 2021, then grew by 0.9% to $21.3 million in 2022, then rose by 22.76% to $26.2 million in 2023, then increased by 23.72% to $32.4 million in 2024, then dropped by 5.37% to $30.6 million in 2025.
- Its Receivables stands at $30.6 million for Q4 2025, versus $30.8 million for Q3 2025 and $30.4 million for Q2 2025.